GlaxoSmithKline has said that Brian McNamara – currently head of its three-year-old consumer health joint venture with Pfizer – will retain the top job at the business after it is hived off
Biogen has reported $2m in sales for newly-launched Alzheimer's therapy Aduhelm that came in below its expectations, prompting the company to issue a rebuke to what it says is "extensive mi
Johnson & Johnson and the 'big three' US pharma wholesalers are on the brink of a $26 billion settlement deal covering thousands of lawsuits alleging their involvement in contributing t
